FR 2025-04818

The Federal Register document details a forthcoming closed meeting held by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. This meeting, involving the Microbiology, Infectious Diseases, and AIDS Research Study Section, is set on April 23-24, 2025, from 11:00 a.m. to 6:00 p.m., and will occur via video assistance. The primary purpose is to review and evaluate specific grant applications. Due to the sensitive nature of the information discussed—such as confidential trade secrets and personal details—the meeting will remain closed to the public in compliance with specific legal provisions.

Summary of the Document

The document serves as a formal announcement of the closed meeting, which focuses on evaluating grant applications related to microbiology, infectious diseases, and AIDS research. Key information includes the date, time, format, and a brief explanation for the closure to the public, citing confidentiality and privacy issues. The meeting aims to ensure that discussions involving potentially sensitive and non-public information are not disclosed unwarrantedly.

Significant Issues or Concerns

Firstly, the document notes the closed nature of the meeting based on confidentiality, yet it does not delve deeply into why these specific criteria necessitate such closure. Public transparency could be enhanced with a more detailed explanation.

Additionally, while the document provides contact information for Kristina Wickham, the Scientific Review Officer, it lacks a secondary contact option. Providing alternative contacts would enhance accessibility and continuity in communication, especially if the primary contact is unavailable.

Public Impact

For the general public, this notice may seem routine, but it underscores the extensive procedural steps taken by government health agencies in protecting sensitive information. While the meeting is not open to public observation or participation, it is crucial in advancing research funding decisions in areas that could significantly impact public health.

Impact on Specific Stakeholders

Researchers and Scientists: For stakeholders directly involved in the grant applications, such as researchers and scientists, the closed meeting is pivotal. It ensures that proprietary research details and personal information are protected, allowing them to submit proposals without fear of unintended disclosure.

Health Agencies and Organizations: Health agencies and affiliated organizations might be interested in the outcomes of such meetings, as they could influence future funding and directions in infectious disease and AIDS research. However, the closed nature guarantees that only relevant and authorized personnel engage in the sensitive parts of the process.

In conclusion, while the document effectively informs about the meeting logistics and upholds compliance with legal statutes on confidentiality, a refined approach in detailing the rationale for closure and ensuring robust contact options could better serve both immediate stakeholders and public interests.